What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Peter E. Lipsky mainly investigates Immunology, Molecular biology, T cell, Internal medicine and Arthritis.
In his study, which falls under the umbrella issue of Immunology, B-cell activating factor and Antibody is strongly linked to CD40.
Peter E. Lipsky interconnects Cellular differentiation, Cell growth, Lymphokine, Antigen and Interleukin 2 in the investigation of issues within Molecular biology.
The T cell study combines topics in areas such as Endothelial stem cell, T lymphocyte, Cell adhesion molecule, Cell biology and Cell–cell interaction.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology, Cyclooxygenase and Pharmacology.
His Arthritis research is multidisciplinary, incorporating perspectives in Clinical trial, Rheumatoid arthritis and Chemotherapy.
His most cited work include:
- Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. (2688 citations)
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial (2178 citations)
- Cyclooxygenase in biology and disease (2105 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Immunology, Molecular biology, T cell, B cell and Cell biology.
Rheumatoid arthritis, Antibody, Immune system, Antigen and Inflammation are the core of his Immunology study.
His research in Rheumatoid arthritis intersects with topics in Autoimmune disease, Surgery, Pathogenesis and Arthritis.
The various areas that he examines in his Molecular biology study include Cell growth, Cytotoxic T cell, CD40, Antigen-presenting cell and Interleukin 2.
His T cell study combines topics from a wide range of disciplines, such as T lymphocyte, Biochemistry, CD3, CD8 and Major histocompatibility complex.
His research in B cell tackles topics such as Endocrinology which are related to areas like Receptor.
He most often published in these fields:
- Immunology (39.53%)
- Molecular biology (34.81%)
- T cell (25.96%)
What were the highlights of his more recent work (between 1999-2021)?
- Immunology (39.53%)
- B cell (18.58%)
- Molecular biology (34.81%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, B cell, Molecular biology, Antibody and Immune system.
His Immunology research incorporates elements of Systemic lupus erythematosus and CD154.
His research integrates issues of Lupus erythematosus, Naive B cell, CD19 and Regulation of gene expression in his study of B cell.
His Molecular biology research integrates issues from Genetics, Gene, CD40, T cell and Germinal center.
The subject of his Rheumatoid arthritis research is within the realm of Internal medicine.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Placebo.
Between 1999 and 2021, his most popular works were:
- Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. (2688 citations)
- Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. (511 citations)
- Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. (510 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Immune system
His primary scientific interests are in Immunology, B cell, Internal medicine, Lupus erythematosus and Immune system.
His study in CD40 extends to Immunology with its themes.
His B cell research is multidisciplinary, relying on both T cell and Molecular biology.
His Internal medicine study incorporates themes from Cyclooxygenase, Endocrinology, Pharmacology and Bioinformatics.
His studies deal with areas such as Arthritis, Adverse effect, Tripterygium wilfordii, Anti-inflammatory and Rheumatoid arthritis as well as Rheumatology.
His Placebo research includes themes of Methotrexate and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
